# Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols

> **NCT00035373** · — · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 767 (actual)

## Conditions studied

- Glioblatoma
- Gliosarcoma
- Anaplastic Astrocytoma
- Oligodendroglioma
- Anaplastic Oligoastrocytoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00035373
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2002-04-19
- **Primary completion:** —
- **Final completion:** 2015-04-29
- **Target enrollment:** 767 (ACTUAL)
- **Last updated:** 2019-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00035373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00035373, "Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00035373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*